Edgecombe M, McLennan A G, Fisher M J
Department of Biochemistry, University of Liverpool, U.K.
Biochem J. 1996 Mar 1;314 ( Pt 2)(Pt 2):687-93. doi: 10.1042/bj3140687.
Diadenosine polyphosphates present in the extracellular environment can, through interaction with appropriate purinoceptors, influence a range of cellular activities. Here we have investigated the nature of the ligand:receptor interactions involved in diadenosine 5',5'''-P1, P4-tetraphosphate (Ap4A)-mediated stimulation of glycogen breakdown in isolated rat liver cells. [2-3H]Ap4A showed specific binding to both intact isolated liver cells and plasma membrane fractions prepared from isolated liver cells. HPLC analysis confirmed that binding was mediated by intact Ap4A and not by potential breakdown products (e.g. ATP, adenosine, etc.). Binding of [2-3H]Ap4A, to isolated liver cell plasma membrane preparations, was successfully displaced by a range of both naturally occurring and synthetic diadenosine polyphospates with the rank order potency Ap4A > or = Ap5A > Ap6A > Ap3A > Ap2A. [2-3H]Ap4A binding was not displaced by P1 effectors but was successfully displaced by a range of P2 effectors with the rank order potency 2-methylthio-ATP > ATP > ATP > or = adenosine 5'-[alpha beta-methylene]triphosphate > adenosine 5'-[beta gamma-methylene]triphospate. These findings are consistent with the interaction of Ap4A with a P2y-like subclass of purinoceptor and are discussed in relation to (1) the known purinoceptor populations in liver cell plasma membranes and (2) observations concerning the binding of diadenosine polyphosphates to purinoceptors in other tissues.
细胞外环境中存在的多磷酸二腺苷可通过与适当的嘌呤受体相互作用,影响一系列细胞活动。在此,我们研究了5',5'''-P1,P4-四磷酸二腺苷(Ap4A)介导的离体大鼠肝细胞糖原分解刺激中配体与受体相互作用的性质。[2-³H]Ap4A显示出与完整的离体肝细胞以及从离体肝细胞制备的质膜组分均有特异性结合。高效液相色谱分析证实,这种结合是由完整的Ap4A介导的,而非潜在的分解产物(如ATP、腺苷等)。[2-³H]Ap4A与离体肝细胞质膜制剂的结合,能被一系列天然存在的和合成的多磷酸二腺苷成功取代,取代效力顺序为Ap4A≥Ap5A>Ap6A>Ap3A>Ap2A。[2-³H]Ap4A的结合不能被P1效应剂取代,但能被一系列P2效应剂成功取代,取代效力顺序为2-甲硫基-ATP>ATP>ATP≥5'-[αβ-亚甲基]三磷酸腺苷>5'-[βγ-亚甲基]三磷酸腺苷。这些发现与Ap4A和嘌呤受体的P2y样亚类相互作用一致,并结合(1)肝细胞质膜中已知的嘌呤受体群体以及(2)关于多磷酸二腺苷与其他组织中嘌呤受体结合的观察结果进行了讨论。